Safe to Assume? Unpacking Regression Assumptions for Utility Data

Author(s)

Humphries B1, Verhoek A2, Kaproulia A3, Tremblay G4, Heeg B5
1Cytel, Toronto, ON, Canada, 2Cytel, Rotterdam, ZH, Netherlands, 3Cytel, Rotterdam, Netherlands, 4Cytel Inc., Waltham, MA, USA, 5Cytel Inc., Rotterdam, ZH, Netherlands

Presentation Documents

OBJECTIVES: Health-related quality-of-life, often reported as utility scores, is an important endpoint in the evaluation of healthcare interventions. Yet the analysis of utility data is complicated by its distributional properties, which raise numerous statistical challenges. As there is no consensus on the most appropriate regression for analyzing utility data, the aim of this paper was to develop a framework to evaluate common regression methods.

METHODS: We reviewed electronic databases (e.g., PubMed) and websites of HTA agencies to identify the most used regression approaches for analyzing utility data. A conceptual framework was then created to illustrate the ability of each regression model to handle the unique distributional features of utility data (i.e., skewed, multimodal, bounded, heteroscedastic, time dependent, with individual or group effects). Using this framework, we examined the strengths and limitations of each approach.

RESULTS: Conventional methods, such as ordinary least squares regression, are widely used to analyze utility data despite violation of key assumptions surrounding normality and independence. While there are advantages in using more complex models, such as mixed effects models, this comes at the cost of untestable assumptions. Some regression assumptions are more robust to violation (e.g., normality of observations) while others are managed at the study design-level (e.g., independence of observations). When selecting a regression approach, ensuring a balance between feasibility, interpretability and statistical correctness is critical.

CONCLUSIONS: Health technology assessment is a process of making statistical inference from clinical, health-related quality of life, and economic data so that decision-makers can assess the value of new technologies. Inappropriate statistical analysis can result in unreliable estimates of cost-effectiveness that fail to provide accurate and robust information to inform resource allocation decisions. This framework provides an overview of the ability of common regression models to analyze utility data, with the aim of supporting evidence-based decision-making.

Conference/Value in Health Info

2022-11, ISPOR Europe 2022, Vienna, Austria

Value in Health, Volume 25, Issue 12S (December 2022)

Code

MSR139

Topic

Methodological & Statistical Research, Patient-Centered Research

Topic Subcategory

Health State Utilities, Patient-reported Outcomes & Quality of Life Outcomes, PRO & Related Methods

Disease

No Additional Disease & Conditions/Specialized Treatment Areas

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×